Right. My main point was this "group" was saying BIEL's products and others were all the same(because they're in same FDA code?), but with minimal digging, you can see the differences.
IMO, I think BIEL and at least Ivivi (from what I have seen) are looking for an additional coding. And this is in the same docket as proposed rule change...
BioElectronics Corporation - Change in Classification Petition
Market Data 
Markets 
AI
